Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Kala Pharmaceuticals Inc (KALA)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 173,142
  • Shares Outstanding, K 33,883
  • Annual Sales, $ 0 K
  • Annual Income, $ -66,740 K
  • 60-Month Beta 1.91
  • Price/Sales 107.24
  • Price/Cash Flow N/A
  • Price/Book 2.06

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 7 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/19
See More
  • Average Estimate -0.74
  • Number of Estimates 4
  • High Estimate -0.70
  • Low Estimate -0.79
  • Prior Year -0.60
  • Growth Rate Est. (year over year) -23.33%

Price Performance

See More
Period Period Low Period High Performance
1-Month
4.85 +15.88%
on 06/13/19
6.15 -8.62%
on 06/04/19
-0.34 (-5.70%)
since 05/17/19
3-Month
4.85 +15.88%
on 06/13/19
8.92 -37.00%
on 04/08/19
-3.05 (-35.18%)
since 03/15/19
52-Week
4.03 +39.45%
on 12/24/18
14.95 -62.41%
on 06/21/18
-7.68 (-57.74%)
since 06/15/18

Most Recent Stories

More News
Kala Pharmaceuticals Reports Inducement Grant Under NASDAQ Listing Rule 5635(c)(4)

Kala Pharmaceuticals, Inc. (NASDAQ:KALA), today announced that the Company granted non-statutory stock options to new employees as inducement awards outside the Company's 2017 Equity Incentive...

KALA : 5.62 (+9.98%)
Kala Pharmaceuticals (KALA) Reports Q1 Loss, Tops Revenue Estimates

Kala Pharma (KALA) delivered earnings and revenue surprises of 17.28% and 43.78%, respectively, for the quarter ended March 2019. Do the numbers hold clues to what lies ahead for the stock?

KALA : 5.62 (+9.98%)
Kala Pharmaceuticals Reports First Quarter 2019 Financial Results

Kala Pharmaceuticals, Inc. (Kala) (NASDAQ:KALA), a biopharmaceutical company focused on the development and commercialization of therapeutics using its proprietary AMPPLIFY(TM) mucus-penetrating...

KALA : 5.62 (+9.98%)
Kala Pharmaceuticals to Present at Bank of America Merrill Lynch 2019 Health Care Conference

Kala Pharmaceuticals, Inc. (NASDAQ:KALA), a biopharmaceutical company focused on the development and commercialization of therapeutics using its proprietary AMPPLIFY(TM) mucus-penetrating...

KALA : 5.62 (+9.98%)
Kala Pharmaceuticals to Report First Quarter 2019 Financial Results and Host Conference Call

Kala Pharmaceuticals, Inc. (NASDAQ:KALA), a biopharmaceutical company focused on the development and commercialization of therapeutics using its proprietary AMPPLIFY(TM) mucus-penetrating...

KALA : 5.62 (+9.98%)
Is the Options Market Predicting a Spike in Kala Pharmaceuticals (KALA) Stock?

Investors need to pay close attention to Kala Pharmaceuticals (KALA) stock based on the movements in the options market lately.

KALA : 5.62 (+9.98%)
Kala Pharmaceuticals Reports Inducement Grant Under NASDAQ Listing Rule 5635(c)(4)

Kala Pharmaceuticals, Inc. (NASDAQ:KALA), today announced that the Company granted non-statutory stock options to new employees as inducement awards outside the Company's 2017 Equity Incentive...

KALA : 5.62 (+9.98%)
Research Report Identifies Dean Foods, Kala Pharmaceuticals, Buckeye Partners, Rockwell Medical, United Fire Group, and Clearwater Paper with Renewed Outlook -- Fundamental Analysis, Calculating Forward Movement

In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Dean Foods Company (NYSE:DF),...

DF : 1.06 (unch)
RMTI : 4.41 (+5.50%)
UFCS : 47.42 (-0.50%)
KALA : 5.62 (+9.98%)
BPL : 40.78 (+0.12%)
CLW : 18.78 (+0.48%)
Kala Pharmaceuticals to Present at the H.C. Wainwright Global Life Sciences Conference

Kala Pharmaceuticals, Inc. (NASDAQ:KALA), a biopharmaceutical company focused on the development and commercialization of therapeutics using its proprietary AMPPLIFY(TM) mucus-penetrating...

KALA : 5.62 (+9.98%)
Implied Volatility Surging for Kala Pharmaceuticals (KALA) Stock Options

Kala Pharmaceuticals (KALA) needs investors to pay close attention to the stock based on moves in the options market lately.

KALA : 5.62 (+9.98%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 32% Sell with a Weakest short term outlook on maintaining the current direction.

Longer term, the trend strength is Average. Long term indicators fully support a continuation of the trend.

See More Share

Trade KALA with:

Business Summary

Kala Pharmaceuticals, Inc. is a biopharmaceutical company. It focused on the development and commercialization of therapeutics through its nanoparticle-based Mucus Penetrating Particles technology. The Company designs proprietary drug delivery technology to penetrate mucosal tissue such as the eyes,...

See More

Key Turning Points

2nd Resistance Point 6.00
1st Resistance Point 5.81
Last Price 5.62
1st Support Level 5.27
2nd Support Level 4.91

See More

52-Week High 14.95
Fibonacci 61.8% 10.78
Fibonacci 50% 9.49
Fibonacci 38.2% 8.20
Last Price 5.62
52-Week Low 4.03

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Read About Upcoming
Changes to This Feature
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar